Patent · US Active

Compounds and methods for reducing undesired toxicity of chemotherapeutic agents

US7829539B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 14, 2007
Grant dateNov 9, 2010
Priority date
Expiry dateMay 5, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel compositions and formulations are disclosed that have use as toxicity-reducing agents for various chemotherapeutic agents and as treatment for certain diseases and conditions. The compositions of matter are amino acid and peptide heteroconjugated disulfides of 2-mercaptoethane sulfonate sodium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.